Evidence map›Paper›PMID 27549073›Full record

ArticleJournal of the American Geriatrics Society2016

Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community Sample.

Mike F Schmidt, Kevin B Freeman, Beverly G Windham, Michael E Griswold, Iftikhar J Kullo, Stephen T Turner, Thomas H Mosley

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Personality and Cognition: The Mediating Role of Inflammatory Markers.The journals of gerontology. Series B, Psychological sciences and social sciences · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Neural correlates linking trauma and physical symptoms.Psychiatry research. Neuroimaging · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mike F SchmidtProgram in Neuroscience, University of Mississippi Medical Center, Jackson, Mississippi.ORCID 0000-0003-4721-1457
Kevin B FreemanDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi.
Beverly G WindhamDepartment of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
Michael E GriswoldCenter of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, Mississippi.
Iftikhar J KulloDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Stephen T TurnerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Thomas H MosleyDepartment of Medicine, University of Mississippi Medical Center, Jackson, Mississippi. tmosley@umc.edu.
University of Mississippi Medical Center · USMayo Clinic · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Genetics of Microangiopathic Brain InjuryR01NS041558 · NINDS · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 2001 to 2010
$5.8M
Proteomic Markers of ArteriosclerosisU01HL081331 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2005 to 2008
$3.7M
NHLBI FAMILY BLOOD PRESSURE PROGRAM (GENOA)U01HL054464 · NHLBI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI TURNER, STEPHEN T · 2000 to 2004
$2.6M
GENETIC DETERMINANTS OF HIGH BLOOD PRESSURE (GENOA)U01HL054463 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI MOSLEY, THOMAS H · 2000 to 2004
$1.6M
NCRR NIH HHS M01 RR000585NHLBI NIH HHS U01 HL054463NHLBI NIH HHS U01 HL054464NHLBI NIH HHS U01 HL081331NINDS NIH HHS R01 NS041558
6 · The paper itself

Abstract

objectivesTo quantify associations between inflammatory biomarkers and hippocampal volume (HV) and to examine effect modification according to sex, race, and age.

designCross-sectional analyses using generalized estimating equations to account for familial clustering; standardized β-coefficients adjusted for age, sex, race, and education.

settingCommunity cohorts in Jackson, Mississippi and Rochester, Minnesota.

participantsThe Genetic Epidemiology Network of Arteriopathy study. MEASUREMENTS: C-reactive protein (CRP), interleukin-6 (IL-6), and soluble tumor necrosis factor receptors 1 (sTNFR-1) and 2 (sTNFR-2) from peripheral blood were measured in a sample of 773 non-Hispanic whites (61% women, aged 60.2 ± 9.8) and 514 African Americans (70% women, aged 63.9 ± 8.1) who also underwent brain magnetic resonance imaging. Biomarkers were standardized and compared according to sex, race and age with HV.

resultsIn the full sample, higher sTNFR-1 and sTNFR-2 were associated with smaller HV. Each standard deviation (SD) increase in sTNFR-1 was associated with 59.1 mm(3) (95% confidence interval (CI) = -101.4 to -16.7 mm(3) ) smaller HV and each SD increase in sTNFR-2 associated with 48.8 mm(3) (95% CI = -92.2 to -5.3 mm(3) ) smaller HV. Relationships were stronger for sTNFR-2 in men (HV = -116.6 mm(3) for each SD increase, 95% CI = -201.0 to -32.1) than women (HV = -26.0 per SD increase, 95% CI = -72.4-20.5) and sTNFR-1 in non-Hispanic whites (HV = -84.7 mm(3) per SD increase, 95% CI = -142.2 to -27.1) than African Americans (HV = -14.1 mm(3) per SD increase, 95% CI = -78.3-50.1). Associations between IL-6 or CRP and HV were not supported.

conclusionHigher levels of sTNFRs were associated cross-sectionally with smaller hippocampi. Longitudinal data are needed to determine whether these biomarkers may help to identify risk of late-life cognitive impairment.

Indexed as

AgedAlgorithmsCluster AnalysisCohort StudiesC-Reactive ProteinCross-Sectional StudiesDominance, CerebralFemaleHippocampusHumansHypertensionImage Interpretation, Computer-AssistedImaging, Three-DimensionalInflammation MediatorsInterleukin-6Magnetic Resonance ImagingC-Reactive ProteinIL6 protein, humanInflammation MediatorsInterleukin-6Receptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIhippocampusinflammationTNF α

Identifiers

PMID27549073
PMCPMC5026883
OpenAlexW2509503242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.